Category: Chronic diseases

Recent clinical guidelines highlight that there is no single "drug of choice" for chronic kidney disease (CKD), but rather a combination therapy is used to manage the complex condition and its comorbidities. For patients with advanced CKD, recent analysis suggests initiating renin-angiotensin system inhibitors may lower the risk of progressing to kidney failure.

Over 54 million adults in the United States have been diagnosed with some form of arthritis, and the quest for a simple cure is understandable. However, there is no single "wonder drug" used to treat arthritis; instead, medical science has developed a range of targeted therapies and innovative treatments that have revolutionized management for different types of the disease. This article explores these advanced medications and the promising research underway for both rheumatoid arthritis and osteoarthritis.

Originally synthesized in the 19th century and first used clinically for asthma in 1922, the primary indication of theophylline is to treat respiratory conditions characterized by reversible airflow obstruction, such as chronic obstructive pulmonary disease (COPD) and asthma. However, its use is now considered second-line due to the availability of safer, more effective treatments.